Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Products>This Product
  Products


High-Definition Erenna® Technology; Powered by Singulex

Product Description

Erenna_w_screen_clear.gif
Singulex, Inc., is a leader in advanced biomarker research, deploying high precision, high sensitivity, digital immunoassay technology to enable groundbreaking discovery, innovate therapies and improved healthcare.

The Erenna® Immunoassay System, powered by Singulex's patented single-molecule detection technology, accurately, precisely and reliably quantifies low-abundance biomarkers at or below sub-picogram concentrations – even in healthy individuals. This unique high-definition technology enhances the clinical utility of biomarkers and allows researchers to gain insights into drug safety and efficacy.

  • Quantifying the Previously Undetectable
  • Uncovering Novel Biology
  • Accelerating Discovery
  • Generating Relevant Data
  • Requiring Fewer Data Points for Critical Decision Making
  • Reducing Program Costs & Improving ROI

The Erenna Immunoassay System includes fully equipped instrumentation, integrated and prepared reagents for high-precision, ultrasensitive immunoassays, and dedicated Sgx link™ software to automatically analyze data and display detailed assay reports. 

The Singulex Solution is flexible to meet your needs and includes the Erenna Immunoassay System, High-Definition Immunoassays and a full range of Custom Services;  Sample Testing, Assay Development and  Antibody Derivatization Services; to accelerate your clinical trials & therapeutics management, and translational life science research.

Unless otherwise noted, Singulex products are for research use only and not intended for diagnostics use.

Contact for More Information.

Product High-Definition Erenna® Technology; Powered by Singulex
Company Singulex - Product Directory
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Singulex - Product Directory
1701 Harbor Bay Parkway, Alameda, California 94502, USA

Tel: +1.888.995.6955
Fax: +1.510.995.9090
Email: info@singulex.com



Scientific News
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!